Biotechnology & Drugs news, Biotechnology & Drugs industry, industry News

▮ More

Novartis Resolves Legacy Litigation Matters, Finalize Settlement Of Speaker Program Litigation

Centogene Obtains FDA Emergency Use Authorization For COVID-19 Molecular Diagnostic Test

CENTOGENE Gets FDA Emergency Use Authorization For COVID-19 Molecular Diagnostic Test

Helsinn, MEI Pharma Discontinue Phase 3 Study With Pracinostat - Quick Facts

Helsinn, MEI Pharma Discontinue Phase 3 Study With Pracinostat After Completing Interim Analysis

Omega's ELISA Antibody Test Approved For COVID-19 Testing In India; Stock Up

Pre-Market Movers In Healthcare Sector - VERO, XERS, CEMI, ZOM...

U.S. Secures Most Of Remdesivir Supply Till September

LMNL Joins COVID-19 Battle, PFE/BNTX Vaccine Data Promising, EVLO On Watch

Accolade Prices IPO Of 10.02 Mln Shares At $22/Shr, Above The Expected Range

Pfizer And BioNTech' Potential Covid-19 Vaccine Shows Positive Data In Human Trial

Stock Alert: AdaptHealth Trading 8% Higher

DURECT Begins Patient Recruitment In Phase 2 Study Of DUR-928 In COVID-19 Patients

Geron Gets EMA COMP Positive Opinion For Imetelstat Orphan Drug Designation

Gilead To Present New Data From Its HIV Research & Development Program - Quick Facts

Golden Biotechnology: FDA Approves Phase II Trial Of Antroquinonol On COVID-19 Patients

Dr. Reddy's Partners With FUJIFILM, Global Response Aid For Avigan Tablets - Quick Facts

EMD Serono, Pfizer: FDA Approves SBLA For BAVENCIO

Accolade To Debut On Nasdaq On July 2

AKRO Soars After-hrs, ATHE On Watch, INO Reports COVID-19 Vaccine Trial Data, ZYNE Down But Not Out

After Market Hours: Akero Therapeutics, FedEx, Carver Bancorp Jump; Chiasma, Steelcase Slip

Stock Alert: OptiNose Up 17%

Sinovac Biotech Ltd. Q1 adjusted earnings of -$0.07 per share

Vertex Pharma: NHS England To Expand Reimbursement Agreement To Include KAFTRIO

FDA OKs Merck's Keytruda As First-line Treatment For Metastatic Colorectal Cancer

Industries >>

Biotechnology & Drugs News

Novartis Resolves Legacy Litigation Matters, Finalize Settlement Of Speaker Program Litigation

CENTOGENE Gets FDA Emergency Use Authorization For COVID-19 Molecular Diagnostic Test

Helsinn, MEI Pharma Discontinue Phase 3 Study With Pracinostat After Completing Interim Analysis